EFTA01344616

Page 2 of II los minient in the Notes imolves certain risks. You should refer to "Selected Risk Considerations' beginning on page 5 of this document and "Risk Factors" beginning on page 5-3 of the prospectus supplement. Neither the U.S. Securities and Exchange Commission, or SEC, nor any state securities commission has approved or disapproved of the Notes or determined that this pricing supplement, or the accompanying prospectus supplement and prospectus, is truthful or complete. Any representation to the contrary is a criminal offense. HSI3C Securities (I 'SA) Inc. or another of our affiliates or agents may inc this pricing supplement in markct•makmg transactions in any Notes atter their initial sale. Unless we or oar agent Informs you otherwise In the confirmation of sale, this pricing supplement will be used in a market-making transaction. IISI3C Securitim (USA) Inc.. an affiliate of ours, will purchase the Notes from us for distribution to the placement agent. See "Supplemental Plan of Distribution (Conflicts of Interest)" on the last page of this pricing supplement. .I. P. Morgan Securities LLC and certain of its registered broker•dealer affiliates arc purchasing the Notes for resale. Price to Public Fees and Commissions Proceeds to Issuer Per Note 51.000 SIO $990 Total 55.950.000 $59,500 $5.890.500 The Notes: Are Not FDIC Insured Are Not Bank Guaranteed May Lose Value JPMorgan Placement Agent March 13.2013 http.//www.sec.gov/Archives/edgar/data/83246/000114420413015558/v338382_424b2.htm 10/29/2013 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0030275 CONFIDENTIAL SDNY GM_00176459 EFTA01344616